Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongying Duan

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Science Translational Medicine|January 17, 2024
Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challengeAmarendra Pegu, Sarah E Lovelace, Megan E DeMouth, et al.
Cell Reports|April 7, 2021
Fusion peptide priming reduces immune responses to HIV-1 envelope trimer baseAngela R Corrigan, Hongying Duan, Cheng Cheng, et al.
Cell Reports|August 7, 2020
Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell SignatureCheng Cheng, Hongying Duan, Kai Xu, et al.
Iscience|February 6, 2024
Long trimer-immunization interval and appropriate adjuvant reduce immune responses to the soluble HIV-1-envelope trimer baseHongying Duan, Angela R Corrigan, Cheng Cheng, et al.
Science Translational Medicine|May 16, 2024
Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized miceChristopher A Cottrell, Xiaozhen Hu, Jeong Hyun Lee, et al.
Iscience|August 9, 2023
Soluble prefusion-closed HIV-envelope trimers with glycan-covered basesAdam S Olia, Cheng Cheng, Tongqing Zhou, et al.
Cell|September 10, 2016
Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor RepertoiresMing Tian, Cheng Cheng, Xuejun Chen, et al.
Eclinicalmedicine|July 5, 2022
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trialKatherine V Houser, Martin R Gaudinski, Myra Happe, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Vaccine Elicitation of HIV-1 Neutralizing Antibodies Against Both V2 Apex and Fusion Peptide in Rhesus MacaquesHongying Duan, Joseph P Nkolola, Shuishu Wang, et al.
Cell Reports|January 30, 2026
Vaccine elicitation of HIV-1 neutralizing antibodies against both V2 apex and fusion peptide in rhesus macaquesHongying Duan, Joseph P Nkolola, Shuishu Wang, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Science Translational Medicine|January 17, 2024
Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challengeAmarendra Pegu, Sarah E Lovelace, Megan E DeMouth, et al.
Cell Reports|April 7, 2021
Fusion peptide priming reduces immune responses to HIV-1 envelope trimer baseAngela R Corrigan, Hongying Duan, Cheng Cheng, et al.
Cell Reports|August 7, 2020
Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell SignatureCheng Cheng, Hongying Duan, Kai Xu, et al.
Iscience|February 6, 2024
Long trimer-immunization interval and appropriate adjuvant reduce immune responses to the soluble HIV-1-envelope trimer baseHongying Duan, Angela R Corrigan, Cheng Cheng, et al.
Science Translational Medicine|May 16, 2024
Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized miceChristopher A Cottrell, Xiaozhen Hu, Jeong Hyun Lee, et al.
Iscience|August 9, 2023
Soluble prefusion-closed HIV-envelope trimers with glycan-covered basesAdam S Olia, Cheng Cheng, Tongqing Zhou, et al.
Cell|September 10, 2016
Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor RepertoiresMing Tian, Cheng Cheng, Xuejun Chen, et al.
Eclinicalmedicine|July 5, 2022
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trialKatherine V Houser, Martin R Gaudinski, Myra Happe, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Vaccine Elicitation of HIV-1 Neutralizing Antibodies Against Both V2 Apex and Fusion Peptide in Rhesus MacaquesHongying Duan, Joseph P Nkolola, Shuishu Wang, et al.
Cell Reports|January 30, 2026
Vaccine elicitation of HIV-1 neutralizing antibodies against both V2 apex and fusion peptide in rhesus macaquesHongying Duan, Joseph P Nkolola, Shuishu Wang, et al.
Pageof 7